Lynda A. Merrill
Director/Board Member at XCR Diagnostics, Inc.
Profile
Lynda A.
Merrill is currently a Director at XCR Diagnostics, Inc. She was previously a Director-Sales & Marketing at Immunodiagnostic Systems Holdings Ltd.
and a Vice President-Industrial Relationships at Gen-Probe, Inc. from 1998 to 2007.
Lynda A. Merrill active positions
Companies | Position | Start |
---|---|---|
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Former positions of Lynda A. Merrill
Companies | Position | End |
---|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2007-11-11 |
IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC | Sales & Marketing | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Immunodiagnostic Systems Holdings Ltd.
Immunodiagnostic Systems Holdings Ltd. Medical SpecialtiesHealth Technology Immunodiagnostic Systems Holdings Plc engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. The company was founded in 1977 and is headquartered in Boldon, the United Kingdom. | Health Technology |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Lynda A. Merrill